S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in

Zacks: Brokerages Anticipate PJT Partners Inc. (NYSE:PJT) Will Announce Quarterly Sales of $229.49 Million

Last updated on Sunday, February 28, 2021 | 2021 MarketBeat

Wall Street brokerages forecast that PJT Partners Inc. (NYSE:PJT) will report sales of $229.49 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for PJT Partners' earnings, with the lowest sales estimate coming in at $200.00 million and the highest estimate coming in at $258.97 million. PJT Partners reported sales of $200.17 million in the same quarter last year, which would suggest a positive year over year growth rate of 14.6%. The company is expected to announce its next quarterly earnings results on Tuesday, April 27th.

According to Zacks, analysts expect that PJT Partners will report full-year sales of $1.06 billion for the current fiscal year, with estimates ranging from $1.04 billion to $1.09 billion. For the next fiscal year, analysts expect that the firm will report sales of $1.17 billion, with estimates ranging from $1.14 billion to $1.19 billion. Zacks Investment Research's sales calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for PJT Partners.

PJT Partners (NYSE:PJT) last issued its earnings results on Tuesday, February 2nd. The financial services provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.11 by $0.70. PJT Partners had a return on equity of 27.00% and a net margin of 9.01%. The firm had revenue of $322.00 million for the quarter, compared to the consensus estimate of $261.69 million.

A number of research analysts have commented on the company. Seaport Global Securities assumed coverage on PJT Partners in a research note on Wednesday, December 16th. They issued a "buy" rating and a $91.00 target price on the stock. Zacks Investment Research upgraded PJT Partners from a "hold" rating to a "buy" rating and set a $86.00 price target for the company in a research note on Friday, December 18th. Five analysts have rated the stock with a buy rating, The stock presently has a consensus rating of "Buy" and an average price target of $76.40.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. GoalVest Advisory LLC bought a new stake in shares of PJT Partners during the 4th quarter worth about $25,000. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in PJT Partners by 45.8% during the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 468 shares of the financial services provider's stock valued at $35,000 after purchasing an additional 147 shares during the period. Lazard Asset Management LLC bought a new stake in PJT Partners during the 4th quarter valued at approximately $43,000. Penbrook Management LLC bought a new stake in PJT Partners during the 4th quarter valued at approximately $55,000. Finally, International Assets Investment Management LLC bought a new stake in PJT Partners during the 4th quarter valued at approximately $63,000. Institutional investors own 68.05% of the company's stock.

Shares of NYSE PJT opened at $69.72 on Friday. The business's 50-day moving average price is $74.47 and its two-hundred day moving average price is $68.58. PJT Partners has a one year low of $23.63 and a one year high of $81.82. The company has a market capitalization of $1.66 billion, a P/E ratio of 19.98 and a beta of 0.90.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 17th. Stockholders of record on Wednesday, March 3rd will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, March 2nd. This represents a $0.20 annualized dividend and a dividend yield of 0.29%. PJT Partners's dividend payout ratio (DPR) is presently 8.30%.

PJT Partners Company Profile

PJT Partners Inc, an investment bank, provides various strategic and shareholder advisory, restructuring and special situations, and private fund advisory and fundraising services to corporations, financial sponsors, institutional investors, and governments worldwide. It offers a range of financial advisory and transaction execution capability, including mergers and acquisitions, joint ventures, minority investments, asset swaps, divestitures, takeover defenses, corporate finance advisory, private placements, and distressed sales.

Recommended Story: Stock Market - What is a circuit breaker?

Get a free copy of the Zacks research report on PJT Partners (PJT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for PJT Partners (NYSE:PJT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]


Analysts Hate These 12 Stocks

When a single Wall Street analyst downgrades one of your stocks, you might think they are just having a bad day or have an incorrect investment thesis. One downgrade typically won't have a significant impact on the price of one of your stocks, but what if analysts repeatedly downgraded a company over the last 30, 60, or 90 days? You would know something is seriously wrong.

Today, we invite you to take a free exclusive look at our up-to-the-minute list of 12 "Most Downgraded" stocks. These are true strong sell stocks. Analysts are abandoning them in droves and issuing rare downgrades and sell ratings. If any of these stocks are lurking around in your portfolio, seriously consider whether or not they still belong in your portfolio. .

View the "Analysts Hate These 12 Stocks".

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.